BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmadpoor P, Rostaing L. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection. Transpl Int. 2020;33:824-825. [PMID: 32236983 DOI: 10.1111/tri.13611] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 33.0] [Reference Citation Analysis]
Number Citing Articles
1 NasrAllah MM, Osman NA, Elalfy M, Malvezzi P, Rostaing L. Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled? Rev Med Virol 2021;31:1-9. [PMID: 32954602 DOI: 10.1002/rmv.2149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gour A, Manhas D, Bag S, Gorain B, Nandi U. Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2. Phytother Res 2021;35:4258-83. [PMID: 33786876 DOI: 10.1002/ptr.7092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Barbara I, Silvia M, Dario T, Giuseppe C, Stallone G. Case Report: Tocilizumab for Acute Kidney Graft Dysfunction in Patient Affected by COVID-19. Front Med (Lausanne) 2021;8:732792. [PMID: 34901054 DOI: 10.3389/fmed.2021.732792] [Reference Citation Analysis]
4 Scherger S, Henao-Martínez A, Franco-Paredes C, Shapiro L. Rethinking interleukin-6 blockade for treatment of COVID-19. Med Hypotheses 2020;144:110053. [PMID: 32758889 DOI: 10.1016/j.mehy.2020.110053] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
5 Montaño LM, Sommer B, Gomez-verjan JC, Morales-paoli GS, Ramírez-salinas GL, Solís-chagoyán H, Sanchez-florentino ZA, Calixto E, Pérez-figueroa GE, Carter R, Jaimez-melgoza R, Romero-martínez BS, Flores-soto E. Theophylline: Old Drug in a New Light, Application in COVID-19 through Computational Studies. IJMS 2022;23:4167. [DOI: 10.3390/ijms23084167] [Reference Citation Analysis]
6 Vivarelli S, Falzone L, Torino F, Scandurra G, Russo G, Bordonaro R, Pappalardo F, Spandidos DA, Raciti G, Libra M. Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review). Int J Oncol 2021;58:145-57. [PMID: 33491759 DOI: 10.3892/ijo.2020.5159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
7 González-Gay MA, Mayo J, Castañeda S, Cifrián JM, Hernández-Rodríguez J. Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces. Expert Opin Biol Ther 2020;20:717-23. [PMID: 32406282 DOI: 10.1080/14712598.2020.1770222] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 García-Montero C, Fraile-Martínez O, Bravo C, Torres-Carranza D, Sanchez-Trujillo L, Gómez-Lahoz AM, Guijarro LG, García-Honduvilla N, Asúnsolo A, Bujan J, Monserrat J, Serrano E, Álvarez-Mon M, De León-Luis JA, Álvarez-Mon MA, Ortega MA. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times. Vaccines (Basel) 2021;9:433. [PMID: 33925526 DOI: 10.3390/vaccines9050433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
9 Bajpai D, Shah S. COVID-19 Pandemic and Pregnancy in Kidney Disease. Adv Chronic Kidney Dis 2020;27:397-403. [PMID: 33308505 DOI: 10.1053/j.ackd.2020.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Satterfield BA, Dikilitas O, Kullo IJ. Leveraging the Electronic Health Record to Address the COVID-19 Pandemic. Mayo Clin Proc 2021;96:1592-608. [PMID: 34088418 DOI: 10.1016/j.mayocp.2021.04.008] [Reference Citation Analysis]
11 Pelaia C, Calabrese C, Garofalo E, Bruni A, Vatrella A, Pelaia G. Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. Int J Mol Sci 2021;22:3059. [PMID: 33802761 DOI: 10.3390/ijms22063059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Bao H, Li G, Fang Y, Lai Q, Bao H, Zheng Y, Hu Y. Immunosuppression and cardiovascular dysfunction in patients with severe versus mild coronavirus disease 2019: a case series. Clin Transl Immunology 2020;9:e1188. [PMID: 33024561 DOI: 10.1002/cti2.1188] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Verma S, Twilley D, Esmear T, Oosthuizen CB, Reid AM, Nel M, Lall N. Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19). Front Pharmacol 2020;11:561334. [PMID: 33101023 DOI: 10.3389/fphar.2020.561334] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
14 Fhon JRS, Silva LM, Diniz-rezende MA, De Araujo JS, De Brito Matiello F, Partezani Rodrigues RA. Cuidado do idoso durante a pandemia no Brasil: análise das matérias jornalísticas. Av enferm 2021;39:10-20. [DOI: 10.15446/av.enferm.v39n1supl.90740] [Reference Citation Analysis]
15 Cortés-ferré HE, Guajardo-flores D, Romero-de La Vega G, Gutierrez-uribe JA. Recovery of Capsaicinoids and Other Phytochemicals Involved With TRPV-1 Receptor to Re-valorize Chili Pepper Waste and Produce Nutraceuticals. Front Sustain Food Syst 2021;4:588534. [DOI: 10.3389/fsufs.2020.588534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Silva TF, Tomiotto-Pellissier F, Sanfelice RA, Gonçalves MD, da Silva Bortoleti BT, Detoni MB, Rodrigues ACJ, Carloto ACM, Concato VM, Siqueira EDS, Costa IN, Pavanelli WR, Conchon-Costa I, Miranda-Sapla MM. A 21st Century Evil: Immunopathology and New Therapies of COVID-19. Front Immunol 2020;11:562264. [PMID: 33193331 DOI: 10.3389/fimmu.2020.562264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Jin X, Zhou W, Luo M, Wang P, Xu Z, Ma K, Cao H, Xu C, Huang Y, Cheng R, Xiao L, Lin X, Pang F, Li Y, Nie H, Jiang Q. Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing. Brief Bioinform 2021:bbab192. [PMID: 34015809 DOI: 10.1093/bib/bbab192] [Reference Citation Analysis]
18 Moreno Fernández-Ayala DJ, Navas P, López-Lluch G. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease. Exp Gerontol 2020;142:111147. [PMID: 33171276 DOI: 10.1016/j.exger.2020.111147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
19 Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev 2020;54:62-75. [PMID: 32513566 DOI: 10.1016/j.cytogfr.2020.06.001] [Cited by in Crossref: 252] [Cited by in F6Publishing: 219] [Article Influence: 126.0] [Reference Citation Analysis]
20 Bui L, Zhu Z, Hawkins S, Cortez-Resendiz A, Bellon A. Vitamin D regulation of the immune system and its implications for COVID-19: A mini review. SAGE Open Med 2021;9:20503121211014073. [PMID: 34046177 DOI: 10.1177/20503121211014073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Staats P, Giannakopoulos G, Blake J, Liebler E, Levy RM. The Use of Non-invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience. Neuromodulation 2020;23:784-8. [PMID: 32342609 DOI: 10.1111/ner.13172] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
22 Brat GA, Weber GM, Gehlenborg N, Avillach P, Palmer NP, Chiovato L, Cimino J, Waitman LR, Omenn GS, Malovini A, Moore JH, Beaulieu-Jones BK, Tibollo V, Murphy SN, Yi SL, Keller MS, Bellazzi R, Hanauer DA, Serret-Larmande A, Gutierrez-Sacristan A, Holmes JJ, Bell DS, Mandl KD, Follett RW, Klann JG, Murad DA, Scudeller L, Bucalo M, Kirchoff K, Craig J, Obeid J, Jouhet V, Griffier R, Cossin S, Moal B, Patel LP, Bellasi A, Prokosch HU, Kraska D, Sliz P, Tan ALM, Ngiam KY, Zambelli A, Mowery DL, Schiver E, Devkota B, Bradford RL, Daniar M, Daniel C, Benoit V, Bey R, Paris N, Serre P, Orlova N, Dubiel J, Hilka M, Jannot AS, Breant S, Leblanc J, Griffon N, Burgun A, Bernaux M, Sandrin A, Salamanca E, Cormont S, Ganslandt T, Gradinger T, Champ J, Boeker M, Martel P, Esteve L, Gramfort A, Grisel O, Leprovost D, Moreau T, Varoquaux G, Vie JJ, Wassermann D, Mensch A, Caucheteux C, Haverkamp C, Lemaitre G, Bosari S, Krantz ID, South A, Cai T, Kohane IS. International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium. NPJ Digit Med 2020;3:109. [PMID: 32864472 DOI: 10.1038/s41746-020-00308-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 18.5] [Reference Citation Analysis]
23 Lauterio A, Valsecchi M, Santambrogio S, De Carlis R, Merli M, Calini A, Centonze L, Buscemi V, Bottiroli M, Puoti M, Fumagalli R, De Carlis L. Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab. Transpl Infect Dis. 2020;e13334. [PMID: 32449235 DOI: 10.1111/tid.13334] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
24 Smail SW, Saeed M, Twana Alkasalias, Khudhur ZO, Younus DA, Rajab MF, Abdulahad WH, Hussain HI, Niaz K, Safdar M. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review. Food Chem Toxicol 2021;150:112087. [PMID: 33640537 DOI: 10.1016/j.fct.2021.112087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Oguz EG, Atilgan KG, Cimen SG, Sahin H, Selen T, Ebinc FA, Cimen S, Ayli MD. COVID-19 infection in a kidney transplant recipient—special emphasis on pharmacokinetic interactions: A case report. World J Transplant 2020; 10(11): 365-371 [PMID: 33312897 DOI: 10.5500/wjt.v10.i11.365] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Manik M, Singh RK. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19. J Med Virol 2021. [PMID: 34672376 DOI: 10.1002/jmv.27405] [Reference Citation Analysis]
27 Swanson KJ, Aziz F, Garg N, Mohamed M, Mandelbrot D, Djamali A, Parajuli S. Role of novel biomarkers in kidney transplantation. World J Transplant 2020; 10(9): 230-255 [PMID: 32995319 DOI: 10.5500/wjt.v10.i9.230] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Costagliola G, Spada E, Consolini R. Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19. Immun Inflamm Dis 2021;9:331-9. [PMID: 33566457 DOI: 10.1002/iid3.404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
29 Faraldo-cabana A, Peix-jiménez B, Fernández-díaz R, Sanz-maría J, Fernández-cruz AM, Ortuño-soriano I. Incidencia de infección por SARS-CoV-2 en pacientes con un trasplante renal funcionante de un hospital terciario de la Comunidad de Madrid. Enferm Nefrol 2022;25:54-8. [DOI: 10.37551/s2254-28842022006] [Reference Citation Analysis]
30 Aguilar-Shea AL, Gutiérrez-Martín-Arroyo J, Vacas-Córdoba M, Gallardo-Mayo C. Reinfection by SARS-CoV-2: The first one in a family reported in Spain. Med Clin (Barc) 2021:S0025-7753(21)00250-5. [PMID: 34103166 DOI: 10.1016/j.medcli.2021.04.009] [Reference Citation Analysis]
31 Kulaga SS, Miller CWT. Viral respiratory infections and psychosis: A review of the literature and the implications of COVID-19. Neurosci Biobehav Rev 2021;127:520-30. [PMID: 33992695 DOI: 10.1016/j.neubiorev.2021.05.008] [Reference Citation Analysis]
32 Guimarães TT, Santos HMBD, Sanctos RTM. PHYSICAL INACTIVITY, CHRONIC DISEASES, IMMUNITY AND COVID-19. Rev Bras Med Esporte 2020;26:378-81. [DOI: 10.1590/1517-8692202026052019_0040] [Reference Citation Analysis]
33 Rhodes A, Martin S, Guarna J, Vowles K, Allen T. A contextual-behavioral perspective on chronic pain during the COVID-19 pandemic and future times of mandated physical distancing. Journal of Contextual Behavioral Science 2020;17:152-8. [DOI: 10.1016/j.jcbs.2020.07.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
34 Ortega MA, Fraile-Martínez O, García-Montero C, García-Gallego S, Sánchez-Trujillo L, Torres-Carranza D, Álvarez-Mon MÁ, Pekarek L, García-Honduvilla N, Bujan J, Álvarez-Mon M, Asúnsolo Á, De la Torre B. An integrative look at SARS‑CoV‑2 (Review). Int J Mol Med 2021;47:415-34. [PMID: 33416095 DOI: 10.3892/ijmm.2020.4828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
35 Bae JH, Choe HJ, Holick MF, Lim S. Association of vitamin D status with COVID-19 and its severity : Vitamin D and COVID-19: a narrative review. Rev Endocr Metab Disord 2022. [PMID: 34982377 DOI: 10.1007/s11154-021-09705-6] [Reference Citation Analysis]
36 [DOI: 10.1101/2020.04.13.20059691] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
37 Chegni H, Babaii H, Hassan ZM, Pourshaban M. Immune response and cytokine storm in SARS-CoV-2 infection: Risk factors, ways of control and treatment. Eur J Inflamm 2022;20:1721727X2210989. [DOI: 10.1177/1721727x221098970] [Reference Citation Analysis]
38 Husain SA, Dube G, Morris H, Fernandez H, Chang JH, Paget K, Sritharan S, Patel S, Pawliczak O, Boehler M, Tsapepas D, Crew RJ, Cohen DJ, Mohan S. Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019. Clin J Am Soc Nephrol 2020;15:1174-8. [PMID: 32423908 DOI: 10.2215/CJN.05170420] [Cited by in Crossref: 50] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
39 Niu H, Zhang Y. THE PROPORTION OF SPORTS PUBLIC SERVICE FACILITIES BASED ON THE DEA MODEL IN COLLEGES AND UNIVERSITIES. Rev Bras Med Esporte 2021;27:97-100. [DOI: 10.1590/1517-8692202127012020_0115] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Jannat K, Paul AK, Bondhon TA, Hasan A, Nawaz M, Jahan R, Mahboob T, Nissapatorn V, Wilairatana P, Pereira ML, Rahmatullah M. Nanotechnology Applications of Flavonoids for Viral Diseases. Pharmaceutics 2021;13:1895. [PMID: 34834309 DOI: 10.3390/pharmaceutics13111895] [Reference Citation Analysis]
41 Askari H, Sanadgol N, Azarnezhad A, Tajbakhsh A, Rafiei H, Safarpour AR, Gheibihayat SM, Raeis-Abdollahi E, Savardashtaki A, Ghanbariasad A, Omidifar N. Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives. Heliyon. 2021;7:e06008. [PMID: 33495739 DOI: 10.1016/j.heliyon.2021.e06008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
42 Ghaffari Rahbar M, Nafar M, Khoshdel A, Dalili N, Abrishami A, Firouzan A, Poorrezagholi F, Samadian F, Ziaie S, Fatemizadeh S, Samavat S. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response? Transpl Infect Dis 2020;22:e13406. [PMID: 32654357 DOI: 10.1111/tid.13406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
43 Sadia A, Basra MAR. Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome. Drug Dev Res 2020. [PMID: 32662099 DOI: 10.1002/ddr.21710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
44 Uberti F, Ruga S, Farghali M, Galla R, Molinari C. A Combination of α-Lipoic Acid (ALA) and Palmitoylethanolamide (PEA) Blocks Endotoxin-Induced Oxidative Stress and Cytokine Storm: A Possible Intervention for COVID-19. J Diet Suppl 2021;:1-23. [PMID: 34405764 DOI: 10.1080/19390211.2021.1966152] [Reference Citation Analysis]
45 Monfared A, Dashti-Khavidaki S, Jafari R, Jafari A, Ramezanzade E, Lebadi MK, Haghdar-Saheli Y, Aghajanzadeh P, Khosravi M, Movassaghi A, Taghvaye-Masoumi H, Alavi Foumani A. Clinical characteristics and outcome of COVID-19 pneumonia in kidney transplant recipients in Razi hospital, Rasht, Iran. Transpl Infect Dis 2020;22:e13420. [PMID: 32681756 DOI: 10.1111/tid.13420] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
46 Nuzzo D, Vasto S, Scalisi L, Cottone S, Cambula G, Rizzo M, Giacomazza D, Picone P. Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge. J Clin Med 2021;10:1947. [PMID: 34062770 DOI: 10.3390/jcm10091947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Tanwar O, Soni A, Prajapat P, Shivhare T, Pandey P, Samaiya PK, Pandey SP, Kar P. Ethyl Pyruvate as a Potential Defense Intervention against Cytokine Storm in COVID-19? ACS Omega 2021;6:7754-60. [PMID: 33778286 DOI: 10.1021/acsomega.1c00157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Aguilar-Shea AL, Gutiérrez-Martín-Arroyo J, Vacas-Córdoba M, Gallardo-Mayo C. Reinfection by SARS-CoV-2: The first one in a family reported in Spain. Med Clin (Engl Ed) 2021;157:e321-3. [PMID: 34754939 DOI: 10.1016/j.medcle.2021.04.010] [Reference Citation Analysis]
49 Liao B, Liu Z, Tang L, Li L, Gan Q, Shi H, Jiao Q, Guan Y, Xie M, He X, Zhao H, Chen W, Liu Y, Li L, Wang Y, Cao Y, Shi Y, Li Y, Lei C. Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. Int J Med Sci 2021;18:29-41. [PMID: 33390771 DOI: 10.7150/ijms.49728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
50 Ahsan H, Sonn JK, Lee YS, Islam SU, Khalil SK. An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay. Viral Immunol 2021. [PMID: 34101517 DOI: 10.1089/vim.2021.0017] [Reference Citation Analysis]
51 Malipiero G, Heffler E, Pelaia C, Puggioni F, Racca F, Ferri S, Spinello L, Merigo M, Lamacchia D, Cataldo G, Sansonna M, Canonica GW, Paoletti G. Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model. Clin Transl Allergy 2020;10:23. [PMID: 32566128 DOI: 10.1186/s13601-020-00333-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
52 Singh U, Hernandez KM, Aronow BJ, Wurtele ES. African Americans and European Americans exhibit distinct gene expression patterns across tissues and tumors associated with immunologic functions and environmental exposures. Sci Rep 2021;11:9905. [PMID: 33972602 DOI: 10.1038/s41598-021-89224-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Mella A, Mingozzi S, Gallo E, Lavacca A, Rossetti M, Clari R, Randone O, Maffei S, Salomone M, Imperiale D, Biancone L. Case series of six kidney transplanted patients with COVID-19 pneumonia treated with tocilizumab. Transpl Infect Dis 2020;22:e13348. [PMID: 32500936 DOI: 10.1111/tid.13348] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
54 Beric-Stojsic B, Kalabalik-Hoganson J, Rizzolo D, Roy S. Childhood Immunization and COVID-19: An Early Narrative Review. Front Public Health 2020;8:587007. [PMID: 33194993 DOI: 10.3389/fpubh.2020.587007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
55 Corrao S, Gervasi F, Di Bernardo F, Argano C. Immune Response Failure in Paucisymptomatic Long-Standing SARS-CoV-2 Spreaders. Clin Pract 2021;11:151-61. [PMID: 33804326 DOI: 10.3390/clinpract11010021] [Reference Citation Analysis]
56 Mascolo S, Carleo MA, Contieri M, Izzo S, Perna A, De Luca A, Esposito V. SARS-CoV-2 and inflammatory responses: From mechanisms to the potential therapeutic use of intravenous immunoglobulin. J Med Virol 2021;93:2654-61. [PMID: 33150961 DOI: 10.1002/jmv.26651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Ulu S, Gungor O, Gok Oguz E, Hasbal NB, Turgut D, Arici M. COVID-19: a novel menace for the practice of nephrology and how to manage it with minor devastation? Ren Fail 2020;42:710-25. [PMID: 32713282 DOI: 10.1080/0886022X.2020.1797791] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
58 Soleimanian S, Yaghobi R. Harnessing Memory NK Cell to Protect Against COVID-19. Front Pharmacol 2020;11:1309. [PMID: 32973527 DOI: 10.3389/fphar.2020.01309] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
59 Zain Mushtaq M, Bin Zafar Mahmood S, Jamil B, Aziz A, Ali SA. Outcome of COVID-19 patients with use of Tocilizumab: A single center experience. Int Immunopharmacol 2020;88:106926. [PMID: 32889236 DOI: 10.1016/j.intimp.2020.106926] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
60 Deng X, Terunuma H, Nieda M. Exploring the Utility of NK Cells in COVID-19. Biomedicines 2022;10:1002. [DOI: 10.3390/biomedicines10051002] [Reference Citation Analysis]
61 Choreño-Parra JA, Jiménez-Álvarez LA, Cruz-Lagunas A, Rodríguez-Reyna TS, Ramírez-Martínez G, Sandoval-Vega M, Hernández-García DL, Choreño-Parra EM, Balderas-Martínez YI, Martinez-Sánchez ME, Márquez-García E, Sciutto E, Moreno-Rodríguez J, Barreto-Rodríguez JO, Vázquez-Rojas H, Centeno-Sáenz GI, Alvarado-Peña N, Salinas-Lara C, Sánchez-Garibay C, Galeana-Cadena D, Hernández G, Mendoza-Milla C, Domínguez A, Granados J, Mena-Hernández L, Pérez-Buenfil LÁ, Domínguez-Cheritt G, Cabello-Gutiérrez C, Luna-Rivero C, Salas-Hernández J, Santillán-Doherty P, Regalado J, Hernández-Martínez A, Orozco L, Ávila-Moreno F, García-Latorre EA, Hernández-Cárdenas CM, Khader SA, Zlotnik A, Zúñiga J. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1). Front Immunol 2021;12:593595. [PMID: 33995342 DOI: 10.3389/fimmu.2021.593595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Gryksa K, Neumann ID. Consequences of pandemic-associated social restrictions: Role of social support and the oxytocin system. Psychoneuroendocrinology 2022;135:105601. [PMID: 34837776 DOI: 10.1016/j.psyneuen.2021.105601] [Reference Citation Analysis]
63 Kusumoputro S, Tseng S, Tse J, Au C, Lau C, Wang X, Xia T. Potential nanoparticle applications for prevention, diagnosis, and treatment of COVID‐19. VIEW 2020;1:20200105. [DOI: 10.1002/viw.20200105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
64 Pelaia C, Tinello C, Vatrella A, De Sarro G, Pelaia G. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications. Ther Adv Respir Dis. 2020;14:1753466620933508. [PMID: 32539627 DOI: 10.1177/1753466620933508] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
65 Yuksel M, Akturk H, Arikan C. Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection. European Journal of Gastroenterology & Hepatology 2020;32:1251-5. [DOI: 10.1097/meg.0000000000001804] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
66 Jacques FH, Apedaile E. Immunopathogenesis of COVID-19: Summary and Possible Interventions. Front Immunol 2020;11:564925. [PMID: 33072103 DOI: 10.3389/fimmu.2020.564925] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
67 Gu T, Zhao S, Jin G, Song M, Zhi Y, Zhao R, Ma F, Zheng Y, Wang K, Liu H, Xin M, Han W, Li X, Dong CD, Liu K, Dong Z. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model. Front Immunol 2020;11:621441. [PMID: 33584719 DOI: 10.3389/fimmu.2020.621441] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
68 Chiodini I, Gatti D, Soranna D, Merlotti D, Mingiano C, Fassio A, Adami G, Falchetti A, Eller-Vainicher C, Rossini M, Persani L, Zambon A, Gennari L. Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes. Front Public Health 2021;9:736665. [PMID: 35004568 DOI: 10.3389/fpubh.2021.736665] [Reference Citation Analysis]
69 Bellini MI, Tortorici F, Capogni M. Kidney transplantation and the lockdown effect. Transpl Int 2020;33:1142-3. [PMID: 32386444 DOI: 10.1111/tri.13639] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
70 Sajna KV, Kamat S. Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2. Cytotherapy 2021;23:101-10. [PMID: 32988772 DOI: 10.1016/j.jcyt.2020.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
71 Brough HA, Kalayci O, Sediva A, Untersmayr E, Munblit D, Rodriguez Del Rio P, Vazquez-Ortiz M, Arasi S, Alvaro-Lozano M, Tsabouri S, Galli E, Beken B, Eigenmann PA. Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - The 2020 COVID-19 pandemic: A statement from the EAACI-section on pediatrics. Pediatr Allergy Immunol 2020;31:442-8. [PMID: 32319129 DOI: 10.1111/pai.13262] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 26.5] [Reference Citation Analysis]
72 Dube GK, Husain SA, McCune KR, Sandoval PR, Ratner LE, Cohen DJ. COVID-19 in pancreas transplant recipients. Transpl Infect Dis 2020;22:e13359. [PMID: 32515076 DOI: 10.1111/tid.13359] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]